
NYSETechnologyInformation Technology Services
ข้อมูลล่าสุด
US$1.635
+US$0.005 · +0.31%
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
ช่วงเวลาซื้อขายปกติ
US$1.635
+US$0.005 · +0.31%
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
ช่วงราคารายวัน
ปัจจุบัน US$1.635
ช่วง 52 สัปดาห์
ปัจจุบัน US$1.635
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
คะแนน GoAI
ขาย
มูลค่า
45
มูลค่ายุติธรรม
ความเชื่อมั่น
66
เชิงบวก
ความเสี่ยง
69
ความเสี่ยงสูง
โมเมนตัม
29
กำลังอ่อนตัว
งานวิจัย GoAI ฉบับเต็ม
ดูข้อมูลสนับสนุน ปัจจัยหนุน และความเสี่ยงในเชิงลึก
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
ช่วงราคารายวัน
ปัจจุบัน US$1.635
ช่วง 52 สัปดาห์
ปัจจุบัน US$1.635
อัตรากำไรที่รายงานในช่วงเวลาที่มีอยู่
รายได้
รายได้จากการดำเนินงาน
รายได้สุทธิ
| รายการ (USD) | ปีงบประมาณ 2025 | ปีงบประมาณ 2024 | ปีงบประมาณ 2023 | ปีงบประมาณ 2022 | ปีงบประมาณ 2021 |
|---|---|---|---|---|---|
| รายได้ | 2.46B USD | 2.56B USD | 2.63B USD | 2.66B USD | 1.88B USD |
| ต้นทุนสินค้าขาย | 833.6M USD | 869.2M USD | 906.4M USD | 954M USD | 626.1M USD |
| กำไรขั้นต้น | 1.62B USD | 1.69B USD | 1.72B USD | 1.71B USD | 1.25B USD |
| การขาย ทั่วไป และธุรการ | 708.6M USD | 727.6M USD | 739.7M USD | 729.9M USD | 643M USD |
| ค่าใช้จ่ายในการดำเนินงาน | 1.55B USD | 1.96B USD | 2.46B USD | 5.63B USD | 1.34B USD |
| ดอกเบี้ยจ่าย | 265.4M USD | 283.4M USD | 293.7M USD | 270.3M USD | 252.5M USD |
| ค่าเสื่อมราคาและค่าตัดจำหน่าย | 757.2M USD | 727M USD | 708.3M USD | 710.5M USD | 537.8M USD |
| รายได้จากการดำเนินงาน | 71.5M USD | −275.6M USD | −734.7M USD | −3.93B USD | −87M USD |
| รายได้สุทธิ | −201.1M USD | −636.7M USD | −911.2M USD | −3.96B USD | −270.5M USD |
ข้อเท็จจริงของบริษัทได้รับการปรับปรุง 9 ต.ค. 2569.
ผลประกอบการล่าสุดที่ประกาศ
ผลประกอบการล่าสุดที่ประกาศ
ประมาณการของนักวิเคราะห์ภายนอกอาจเปลี่ยนแปลงและไม่ใช่คำแนะนำของ GoAI
กองทุนซื้อขายแลกเปลี่ยนที่รายงานความเสี่ยงต่อหุ้นนี้
Avantis U.S. Small Cap Value ETFAVUV23.39M0.08%30.82B USD0.25%US$119.79-0.28%
iShares Russell 2000 ETFIWM15.19M0.02%77.7B USD0.19%US$278.02+0.16%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV10.88M0.04%26.91B USD0.33%US$37.965-0.35%
Vanguard Extended Market ETFVXF10.21M0.01%95.4B USD0.05%US$233.59+0.20%
iShares Russell 2000 Value ETFIWN5.31M0.04%13.75B USD0.24%US$210.79-0.08%
Vanguard Russell 2000 ETFVTWO4.12M0.02%18B USD0.06%US$112.3+0.18%
EA Bridgeway Omni Small-Cap Value ETFBSVO3.88M0.16%2.43B USD0.45%US$28.475-0.28%
Dimensional - US Targeted Value ETFDFAT3.82M0.01%30.26B USD0.33%US$67.365-0.29%
Avantis U.S. Small Cap Value ETFAVUV
iShares Russell 2000 ETFIWM
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
iShares Russell 2000 Value ETFIWN
Vanguard Russell 2000 ETFVTWO
EA Bridgeway Omni Small-Cap Value ETFBSVO
Dimensional - US Targeted Value ETFDFATเนื้อหาที่สร้างโดย AI และข้อมูลตลาดที่ล่าช้ามีไว้เพื่อให้ข้อมูลและการศึกษาเท่านั้น ไม่ใช่คำแนะนำการลงทุน